Revolution Medicines · 1 day ago
Director, Marketing
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Director of Marketing will support the development and delivery of marketing plans for the company's lead RAS(ON) programs, collaborating with cross-functional teams to execute critical marketing activities and manage relationships with external agencies.
Health CareLife ScienceMedical
Responsibilities
Operate as an ambassador of the company, establishing the organization as trusted member of the healthcare community to all relevant stakeholders
Lead the development of effective strategic and promotional plans, shape launch strategy to align with full brand and portfolio strategy
Leverage deep understanding of oncology healthcare customers, including providers, key opinion leaders, patients, and market access stakeholders, to inform the brand strategic approach that drives customer behavior change and market performance
Lead implementation of brand/launch strategies through development of effective promotional materials for key customer segments (e.g., HCPs, patients, KOLs, allied health professionals, market access stakeholders) and across multiple channels
Contribute to vision for product/brand lifecycle, incorporating portfolio/pan tumor considerations
Prioritize key workstreams and tactics across multiple lung cancer molecules
Mentor and coach peer marketing team members who may be supporting key workstreams
Oversee critical cross functional workstreams to support launch readiness and success
Leverage insights to inform stakeholder segmentation, channel mix, and targeting of customer segments
Ensure tactical execution is aligned to brand/launch strategies and stakeholder insights
Maintain expertise in disease state, competitive landscape, and market dynamics, informing potential pivots in strategic and executional approach as needed
Partner with internal stakeholders to develop and deliver impactful customer-facing content
Partner with Analytics & Insights to shape market research, inform key performance metrics, and measure the effectiveness of marketing initiatives
Ensure management of agency of record relationships, workflow, and budgets
Ensure strategic and tactical plans meet compliance and regulatory guidelines and company policies
Manage marketing operating expenses within budget
Travel as needed to home office as applicable and external meetings and conferences
Other duties as assigned
Qualification
Required
Bachelor's degree required with at least 15 years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and omnichannel marketing
Strong leadership skills, with the ability to work well cross-functionally and influence across an organization at all levels
Proven track record of developing and executing effective marketing initiatives
Demonstrated analytical and problem-solving skills, leading to the development of innovative marketing initiatives
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
Strong interpersonal skills, with demonstrated ability to lead and influence cross-functional partners
Exceptional communication skills, including excellent written and verbal communication skills; possesses a professional, proactive demeanor
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patient
Ability to represent Revolution Medicines well externally
Preferred
MBA
Launch and customer-facing experience
Experience with targeted oncology products
Experience in a smaller, rapidly growing, company
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
2025-12-18
2025-12-18
Company data provided by crunchbase